pubmed:abstractText |
210 cases of scrofulous sinus has been reported. Baluodan (BLD) has removed necrotic tissue and promote the granulation. It had potent inhibition on TB with no side effect in animal experiments and clinical trials. The total effective rate was 98.57%. The average of treatment course was 39.0 +/- 13.7 days. Follow-up for 2-4 years showed 3 cases had recurrence (1.4%). Its advantages were high effective rate, short curative course, low recurrence rate, with convenient in administration, and easy to spread.
|